A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum

Biotechnology Letters

Volumn 29, Issue 8, 2007, Pages 1249-1253

  Reyes Escogido, M L ^a   De Leon Rodriguez A ^a   Barba De La Rosa, A P ^a  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

Author keywords

Cytokine; Delivery systems; Protein expression; Sec pathway; Synthetic gene

Indexed keywords

BIOTECHNOLOGY; CELLS; ENZYME ACTIVITY; ESCHERICHIA COLI; PEPTIDES;

BIFIDOBACTERIUM; CYTOKINE; DELIVERY SYSTEMS; PROTEIN EXPRESSION; SYNTHETIC GENES;

GENE EXPRESSION;

INTERLEUKIN 10; RECOMBINANT PROTEIN;

ARTICLE; BIFIDOBACTERIUM; BIOTECHNOLOGY; CHEMISTRY; CODON; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE VECTOR; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PLASMID; PROMOTER REGION;

BASE SEQUENCE; BIFIDOBACTERIUM; BIOTECHNOLOGY; CODON; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; INTERLEUKIN-10; MOLECULAR SEQUENCE DATA; PLASMIDS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS;

BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; ESCHERICHIA COLI;

EID: 34447118984     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-007-9376-8     Document Type: Article

References (13)

1. Argnani A, Leer RJ, van Luijk N, Pouwels PH (1996) A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium. Microbiology 142:109-114
2. de Waal MR, Moore KW (1998) Interleukin-10. In: Thomson A (ed) The cytokine handbook, 3rd edn. San Diego, CA, Academic Press, pp 333-364
3. Fu GF, Li X, Hou YY, Fan YR, Liu WH, Xu GX (2005) Bifidobacterium longum as an oral delivery system of endostatine for gene therapy on solid liver cancer. Cancer Gene Ther 12:133-140
4. Fujimori M, Amano J, Taniguchi S (2002) The genus Bifidobacterium for cancer gene therapy. Curr Opin Drug Discov Devel 5:200-203
5. Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512-519
6. Kimura NT, Taniguchi S, Aoki K, Baba T (1998) Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res 40:2061-2068
7. Moller PL, Jorgensen F, Hansen OC, Madsen SM, Stougaard P (2001) Intra and extracellular β-galactosidases from Bifidobacterium bifidum and B. infantis: Molecular cloning, heterologous expression, and comparative characterization. Appl Environ Microbiol 67:2276-2283
8. Rhim SL, Park MS, Ji GE (2006) Expression and secretion of Bifidobacterium adolescentis amylase by Bifidobacterium longum. Biotechnol Lett 28:163-168
9. Schotte L, Steidler L, Vandekerckhove J, Remaut E (2000) Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme Microbiol Technol 27:761-765
10. Takeuchi A, Matsumura H, Kano Y (2002) Cloning and expression in Escherichia coli of a gene, hup, encoding the histone-like protein HU of Bifidobacterium longum. Biosci Biotech Biochem 66:598-603
11. Theys J, Barbé S, Landuyt S, Nuyts L, Mellaert V, Wouters B, Anné J, Lambin P (2003) Tumor specific gene delivery using genetically engineered bacteria. Curr Gene Ther 3:207-221
12. Yazawa K, Fujimori M, Nakamura T, Sasaki T, Amano J, Kano Y, Taniguchi S (2001) Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res Treat 66:165-170
13. Yi C, Huang Y, Guo ZY, Wang S (2005) Antitumor effect of cytosine deaminase/5-flurocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin 26:629-634